◀ Back to NFKB1
ACE — NFKB1
Text-mined interactions from Literome
Yoshiyama et al., J Mol Cell Cardiol 2001
(Myocardial Infarction) :
ACE inhibitor and ARB
inhibited JNKs,
NF- kappa B and AP-1 activities
Cominacini et al., Am J Hypertens 2002
:
In this study we have compared the
effects of two different
angiotensin converting enzyme (ACE) inhibitors, one possessing an active sulfhydryl group ( zofenopril ) and one lacking this group ( enalapril ) on the cellular redox state ( monitored by measuring intracellular reactive oxygen species and thiol status ), expression of adhesion molecules, and activation of
NF-kappaB in human umbilical vein endothelial cells ( HUVECs )
Sasaki et al., Am J Physiol Regul Integr Comp Physiol 2005
(Dehydration...) :
Furthermore, the same
ACE inhibitor and AT1-receptor antagonist each
increased the resting
NF-kappaB activity in the liver and spleen, although they had no effect on the LPS induced splenic expression of NF-kappaB
Watanabe et al., Peptides 2006
:
Furthermore, both an
angiotensin-converting-enzyme (ACE) inhibitor and an AT1 receptor antagonist
enhanced ( rather than reduced ) the
NF-kappaB and AP-1 activities in the hippocampus and/or cerebellum of rats given LPS
Miguel-Carrasco et al., Journal of inflammation (London, England) 2010
:
To understand the mechanisms involved in the effect of captopril, mRNA expression of
ACE , angiotensin II type I receptor (AT1R) and p22phox ( a subunit of NADPH oxidase ), as well as
NF-kappaB activation and expression, were measured in the left ventricle of these animals
Klahr et al., Kidney Int Suppl 1997
(Kidney Diseases...) :
ACE inhibition, AT-1 and AT-2 receptor blockade each differentially
attenuated NF-kappa B isotype activation